Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody-mediated Rejection in Kidney Transplant”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Not applicableStudy completedNCT03098238
What this trial is testing

Endothelial Microparticules and Antibody Mediated Rejection and Kidney Transplantation: Biomarker of Antibody-mediated Rejection in Kidney Transplantation

Who this might be right for
Renal Transplantation
University Hospital, Montpellier 249
Testing effectiveness (Phase 2)Looking for participantsNCT06744647
What this trial is testing

Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation

Who this might be right for
Antibody-Mediated RejectionKidney TransplantationBiopsy-proven Histologic Scores+1 more
Alexion Pharmaceuticals, Inc. 45
Not applicableStudy completedNCT05452317
What this trial is testing

Assess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated Rejection

Who this might be right for
Antibody-mediated Rejection in Kidney Transplant
CSL Behring 52
Testing effectiveness (Phase 2)Study completedNCT01134510
What this trial is testing

Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection

Who this might be right for
Kidney Transplantation
Stanley Jordan, MD 20
Testing effectiveness (Phase 2)Ended earlyNCT01630538
What this trial is testing

Cyclophosphamide Therapy for Refractory Antibody-Mediated Rejection (AMR) in Kidney Transplants

Who this might be right for
Antibody Mediated Rejection
University of Manitoba 4
Not applicableActive Not RecruitingNCT07316829
What this trial is testing

TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS

Who this might be right for
Graft RejectionKidney TransplantationLung Transplantation+6 more
Fondazione IRCCS Policlinico San Matteo di Pavia 30
Post-approval studies (Phase 4)WithdrawnNCT02130817
What this trial is testing

Belatacept in Kidney Transplantation of Moderately Sensitized Patients

Who this might be right for
End Stage Renal DiseaseAntibody Mediated Rejection
University of Wisconsin, Madison
Not applicableEnded earlyNCT02120482
What this trial is testing

Combined Apheresis for ABO-incompatible Transplantation - a Pilot Study

Who this might be right for
Decreased Immunologic ActivityAntibody-mediated Rejection
Medical University of Vienna 4
Not applicableNot Yet RecruitingNCT05779124
What this trial is testing

BAFF/APRIL in Kidney Transplant Rejection Risk Assessment

Who this might be right for
Kidney TransplantationKidney Transplant Rejection
First Affiliated Hospital, Sun Yat-Sen University 176
Not applicableLooking for participantsNCT04870437
What this trial is testing

Impact of ExtraCorporeal Phototherapy (ECP) on Auxiliary Follicular T-lymphocytes and Circulating B-lymphocytes During Chronic AntiBody-Mediated Rejection in Kidney Transplantation.

Who this might be right for
Kidney Transplantation
University Hospital, Angers 30
Not applicableStudy completedNCT03737136
What this trial is testing

Comparison Between Bortezomib and Rituximab Plus Plasmapheresis in AMR

Who this might be right for
Antibody-mediated Rejection
Shahid Beheshti University of Medical Sciences 20
Not applicableUnknownNCT06013358
What this trial is testing

DdcfDNA in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Seoul National University Hospital 200
Large-scale testing (Phase 3)Ended earlyNCT03994783
What this trial is testing

Transplant Antibody-Mediated Rejection: Guiding Effective Treatments

Who this might be right for
Kidney Transplant RejectionAntibody-mediated Rejection
Imperial College London 3
Testing effectiveness (Phase 2)Study completedNCT01567085
What this trial is testing

Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased Donor

Who this might be right for
Stage V Chronic Kidney Disease
Alexion Pharmaceuticals, Inc. 80
Testing effectiveness (Phase 2)Study completedNCT02936479
What this trial is testing

C1-Inhibitor (INH) for Refractory Antibody Mediated Renal Allograft Rejection

Who this might be right for
Antibody Mediated Rejection of Kidney Transplant
NYU Langone Health 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06453135
What this trial is testing

Eculizumab for Prevention of Antibody-Mediated Rejection in ABO-Incompatible Living Donor Kidney Transplantation

Who this might be right for
Kidney Transplantation
Tao Lin 30
Not applicableEnded earlyNCT03585855
What this trial is testing

Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Antibody Mediated Kidney Graft Rejection (ABMR)

Who this might be right for
Interventional
University Medical Centre Ljubljana 4
Testing effectiveness (Phase 2)WithdrawnNCT01035593
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation

Who this might be right for
Graft RejectionKidney Transplantation
Pharming Technologies B.V.
Testing effectiveness (Phase 2)Study completedNCT02738918
What this trial is testing

Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study.

Who this might be right for
Renal TransplantAcute Antibody Mediated RejectionMild Immunologic Risk Factor
Assistance Publique - Hôpitaux de Paris 51
Early research (Phase 1)Looking for participantsNCT05456243
What this trial is testing

Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Mayo Clinic 12
Load More Results